Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 9.0B | 11.6B | 9.2B | 9.7B |
| Cost of revenue | 6.2B | 8.9B | 6.5B | 6.8B |
| Gross profit | 2.8B | 2.8B | 2.7B | 2.9B |
| Operating expense | ||||
| Research & development | 889.9M | 941.4M | 732.9M | 686.6M |
| Selling general and admin | 727.8M | -1.4B | 1.8B | -185.3M |
| Other operating expenses | 55.8M | 74.5M | 52.2M | 58.2M |
| Operating income | 1.2B | 1.3B | 1.3B | 1.5B |
| Non operating interest income | ||||
| Income | 51.8M | 50.4M | 53.8M | 52.2M |
| Expense | 34.1M | 37.9M | 41.9M | 47.8M |
| Other income expense | — | — | — | — |
| Pretax income | 1.4B | 956.2M | 1.4B | 1.4B |
| Tax provision | 67.8M | 24.8M | 128.7M | 111.1M |
| Net income | 1.3B | 931.4M | 1.3B | 1.3B |
| Basic EPS | 0.5 | — | — | — |
| Diluted EPS | 0.5 | — | — | — |
| Basic average shares | 2.7B | — | — | — |
| Diluted average shares | 2.7B | — | — | — |
| EBITDA | 1.5B | 1.4B | 1.3B | 1.6B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -20.7M | 245.5K | -31.3M | -17.5M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |